A Chinese laser blood test detects lung cancer years before CT scans, showing promise for early diagnosis.

The NIH is testing ivermectin’s cancer-fighting potential, sparking scientific and political concerns.

Mouser Electronics now distributes iC-Haus's specialized chips and sensors for industrial, automotive, medical, and robotics uses.

UT Austin relocates its $2.5B medical center from downtown to Northwest Austin’s Domain area due to space and integration issues.

St. Jude's CEO James Downing will step down in late 2026 after 12 years, transitioning to a faculty role as a search for his successor begins.

Three Annexon insiders sold $104K in stock Feb 18, reducing stakes by 6.5%-7.5%, as shares closed at $4.90 on Feb 20.

A pharmacist suggests a mineral may help prevent 3 a.m. wake-ups, but details and evidence were lacking.

India and Brazil signed an agreement to cooperate on pharmaceutical regulations, aiming to improve safety, quality, and access to medical products.

REGENXBIO faces lawsuit for misleading investors about RGX-111 gene therapy safety, after FDA halted trials due to a participant’s brain tumor.

The FDA approved BYSANTI, a new antipsychotic for bipolar mania and schizophrenia, with a U.S. launch expected in Q3 2026.